United States · FDA National Drug Code directory
Teglutik
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70726-0305_4746c4d8-402a-0390-e063-6294a90a7fc2
- Product NDC
- 70726-0305
- Form
- LIQUID
- Composition / generic term
- Riluzole
- Labeler
- EDW PHARMA
- Marketing category
- UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
- Marketing start / end (source format)
- 20240308
- Source listing expiry
- 20261231
Source-listed ingredients
- RILUZOLE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 300 mL in 1 BOTTLE, PLASTIC (70726-0305-1) · 70726-0305-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →